Indivior PLC (LON:INDV – Get Free Report)’s share price crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 803.50 ($10.52) and traded as low as GBX 671 ($8.78). Indivior shares last traded at GBX 687 ($8.99), with a volume of 339,070 shares.
Analyst Upgrades and Downgrades
Separately, Jefferies Financial Group restated a “buy” rating and issued a GBX 1,800 ($23.56) target price on shares of Indivior in a research note on Tuesday, December 17th.
View Our Latest Analysis on Indivior
Indivior Trading Down 0.6 %
Indivior Company Profile
Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.
Read More
- Five stocks we like better than Indivior
- Are Penny Stocks a Good Fit for Your Portfolio?
- Is McDonald’s Stock Serving a Value Meal to Investors?
- What Are Dividend Achievers? An Introduction
- Walgreens Comeback? Private Equity Circling for a Buyout
- How to Calculate Inflation Rate
- Coca-Cola Stock Looks Refreshing After the Relief Rally
Receive News & Ratings for Indivior Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Indivior and related companies with MarketBeat.com's FREE daily email newsletter.